BIIB logo

Biogen (BIIB) Company Overview

Profile

Full Name:

Biogen Inc.

Sector:

Healthcare

Country:

United States

IPO:

September 17, 1991

Description:

Biogen Inc. is a global biopharmaceutical company specializing in the discovery, development, and sale of innovative drugs for the treatment of serious neurological, neuroimmune, and neurodegenerative diseases: multiple sclerosis, Alzheimer's disease, dementia, movement disorders (including Parkinson's disease), neuromuscular disorders (including spinal muscular atrophy, amyotrophic lateral sclerosis). The company's activities are also focused on discovering and developing innovative treatments for hematological diseases, neurocognitive disorders, pain, ophthalmology, and rare genetic diseases. Biogen Inc. also manufactures and sells biological analogues of advanced biological drugs. The company was founded in 1978 and is headquartered in Cambridge, Massachusetts.

Key Details

Price

$151.98

Annual Revenue

$9.68 B(-1.62% YoY)

Annual EPS

$11.18(+40.28% YoY)

Beta

0.44

Events Calendar

Earnings

Next earnings date:

Apr 24, 2025

Recent quarterly earnings:

Feb 12, 2025

Recent annual earnings:

Feb 12, 2025
Dividend

Next ex-dividend date:

N/A

Recent ex-dividend date:

N/A
Splits

Next split:

N/A

Recent split:

Jan 18, 2001

Analyst ratings

Recent major analysts updates

Feb 18, 25 Piper Sandler
Neutral
Feb 13, 25 Wells Fargo
Equal-Weight
Feb 13, 25 Truist Securities
Buy
Feb 13, 25 Scotiabank
Sector Outperform
Feb 13, 25 RBC Capital
Outperform
Feb 13, 25 Needham
Hold
Feb 13, 25 Morgan Stanley
Equal-Weight
Feb 13, 25 HC Wainwright & Co.
Buy
Feb 13, 25 Goldman Sachs
Buy
Feb 13, 25 Citigroup
Neutral

Market Data

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Price

Market cap

Technical

Dividend

Profitability

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Revenue

Profit

EPS

ROA & ROE

EBIT & EBITDA

Valuation

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

PE Ratio

PB Ratio

PS Ratio

Enterprise value

EV/EBITDA

Financial Health

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Liquidity

Leverage

Risk & Stability

Balance Sheet

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Assets

Equity

Liabilities

Debt

Expenses

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Cash Flow

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Cashflow Activities

Free CashFlow

CAPEX

Institutional Ownership

FAQ

  • What is the ticker symbol for Biogen?
  • Does Biogen pay dividends?
  • What sector is Biogen in?
  • What industry is Biogen in?
  • What country is Biogen based in?
  • When did Biogen go public?
  • Is Biogen in the S&P 500?
  • Is Biogen in the NASDAQ 100?
  • Is Biogen in the Dow Jones?
  • When was Biogen's last earnings report?
  • When does Biogen report earnings?
  • Should I buy Biogen stock now?

What is the ticker symbol for Biogen?

The ticker symbol for Biogen is NASDAQ:BIIB

Does Biogen pay dividends?

No, Biogen does not pay dividends

What sector is Biogen in?

Biogen is in the Healthcare sector

What industry is Biogen in?

Biogen is in the Drug Manufacturers - General industry

What country is Biogen based in?

Biogen is headquartered in United States

When did Biogen go public?

Biogen's initial public offering (IPO) was on September 17, 1991

Is Biogen in the S&P 500?

Yes, Biogen is included in the S&P 500 index

Is Biogen in the NASDAQ 100?

Yes, Biogen is included in the NASDAQ 100 index

Is Biogen in the Dow Jones?

No, Biogen is not included in the Dow Jones index

When was Biogen's last earnings report?

Biogen's most recent earnings report was on Feb 12, 2025

When does Biogen report earnings?

The next expected earnings date for Biogen is Apr 24, 2025

Should I buy Biogen stock now?

As of today, analysts generally recommend a 'Buy' rating. However, it's important to do your own research and consider your financial situation before making any investment decisions